Availability for Non-Exclusive, Exclusive, or Partially Exclusive Licensing of U.S. Provisional Patent Application Concerning Novel Use and Method of Rapamycin To Treat Toxic Shock

Riepilogo

Announcement is made of the availability for licensing of the invention set forth in U.S. Provisional Patent Application Serial No. 61/231,348 entitled "Novel Use and Method of Rapamycin to Treat Toxic Shock," filed August 5, 2009. The United States Government, as represented by the Secretary of the Army, has rights to this invention.